Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Gross-Profit-to-Asset % : 10.91% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Zhejiang Shapuaisi Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Sep. 2024 was ¥232.6 Mil. Zhejiang Shapuaisi Pharmaceutical Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥2,131.8 Mil. Therefore, Zhejiang Shapuaisi Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 10.91%.

Zhejiang Shapuaisi Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Gross-Profit-to-Asset % Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

21.11

10.64

24.80

18.16

17.50

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															16.32	15.45	13.07	9.50	10.91

Competitive Comparison of Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset % falls into.

Zhejiang Shapuaisi Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Zhejiang Shapuaisi Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	361.038	/	( (1956.493	+	2170.297)	/ 2 )
	=	361.038	/	2063.395
	=	17.50 %

Zhejiang Shapuaisi Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	232.564	/	( (2145.273	+	2118.346)	/ 2 )
	=	232.564	/	2131.8095
	=	10.91 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Zhejiang Shapuaisi Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Zhejiang Shapuaisi Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shapuaisi Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

N/A

Address

No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200

Website

http://www.zjspas.com

Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicine, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.

Executives

Huang Ming Xiong	Directors, senior managers
Wu Jian Guo	Director
Xu Hong Sheng	senior management
Hu Zheng Guo	Director
Ge Sheng Fang	Director
Feng Xiao	Supervisors
Chen De Kang	Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines